Literature DB >> 21945248

Camelpox virus.

Sophie Duraffour1, Hermann Meyer, Graciela Andrei, Robert Snoeck.   

Abstract

Camelpox virus (CMLV) causes a smallpox-like illness in a unique host, the camel. The disease is enzootic in almost all regions where camel husbandry is practiced, and is responsible for severe economic losses. Although it is genetically the closest known virus to variola virus, the etiologic agent of smallpox, CMLV remains poorly studied. It is characterized by a narrow host range, the capacity to induce giant cells in culture and to counteract host immune defenses; however, the genetic bases associated with these features are not understood. Also, it still needs to be demonstrated whether CMLV strains of variable virulence circulate and how arthropod vectors might be involved in virus transmission. Current evidence indicates that, under certain circumstances, CMLV can be mildly pathogenic in humans. A reservoir host other than camels is unlikely to exist. We review here current knowledge of CMLV, including clinical and laboratory aspects of the disease. We also discuss prevention and therapy by use of vaccines and antiviral treatments, as well as the possibility of camelpox eradication.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945248     DOI: 10.1016/j.antiviral.2011.09.003

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  14 in total

1.  Analysis of TK and C18L genes of wild-type and cell culture passaged camelpox virus.

Authors:  Muaz M Abdellatif; Bashir Salim; Awad A Ibrahim; Tigani Asil; Abdelmalik I Khalafalla
Journal:  Virol Sin       Date:  2013-07-24       Impact factor: 4.327

2.  Camelpox, an emerging orthopox viral disease.

Authors:  Vinayagamurthy Balamurugan; Gnanavel Venkatesan; Veerakyathappa Bhanuprakash; Raj Kumar Singh
Journal:  Indian J Virol       Date:  2013-07-16

Review 3.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

4.  An increasing danger of zoonotic orthopoxvirus infections.

Authors:  Sergei N Shchelkunov
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

5.  First Diagnosed Case of Camelpox Virus in Israel.

Authors:  Oran Erster; Sharon Melamed; Nir Paran; Shay Weiss; Yevgeny Khinich; Boris Gelman; Aharon Solomony; Orly Laskar-Levy
Journal:  Viruses       Date:  2018-02-13       Impact factor: 5.048

6.  Complete Genome Sequence of the First Camelpox Virus Case Diagnosed in Israel.

Authors:  Ofir Israeli; Inbar Cohen-Gihon; Anat Zvi; Ohad Shifman; Sharon Melamed; Nir Paran; Orly Laskar-Levy; Adi Beth-Din
Journal:  Microbiol Resour Announc       Date:  2019-08-22

7.  More cell culture passaged Camelpox virus sequences found resembling those of vaccinia virus.

Authors:  Abdelmalik I Khalafalla; Mohamed A Al Hosani; Hassan Zackaria Ali Ishag; Salama S Al Muhairi
Journal:  Open Vet J       Date:  2020-04-23

8.  Genome Sequences of Akhmeta Virus, an Early Divergent Old World Orthopoxvirus.

Authors:  Jinxin Gao; Crystal Gigante; Ekaterine Khmaladze; Pengbo Liu; Shiyuyun Tang; Kimberly Wilkins; Kun Zhao; Whitni Davidson; Yoshinori Nakazawa; Giorgi Maghlakelidze; Marika Geleishvili; Maka Kokhreidze; Darin S Carroll; Ginny Emerson; Yu Li
Journal:  Viruses       Date:  2018-05-12       Impact factor: 5.048

9.  Camelid type I interferons: Identification and functional characterization of interferon alpha from the dromedary camel (Camelus dromedarius).

Authors:  Avinash Premraj; Abi George Aleyas; Binita Nautiyal; Thaha Jamal Rasool
Journal:  Mol Immunol       Date:  2020-01-31       Impact factor: 4.407

10.  ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.

Authors:  Sophie Duraffour; María M Lorenzo; Gudrun Zöller; Dimitri Topalis; Doug Grosenbach; Dennis E Hruby; Graciela Andrei; Rafael Blasco; Hermann Meyer; Robert Snoeck
Journal:  J Antimicrob Chemother       Date:  2015-01-27       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.